n-vinyl-2-pyrrolidinone has been researched along with Insulin Resistance in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (66.67) | 24.3611 |
2020's | 1 (33.33) | 2.80 |
Authors | Studies |
---|---|
Chen, J; Lin, Y; Liu, J; Wang, FB; Wang, L; Zhang, X; Zhang, ZX; Zhou, Z | 1 |
Arai, H; Araki, E; Ishibashi, S; Matsuba, I; Matsuba, R; Suganami, H; Yamashita, S; Yokote, K | 1 |
Cakır, U; Gurluler, E; Kara, M | 1 |
1 trial(s) available for n-vinyl-2-pyrrolidinone and Insulin Resistance
Article | Year |
---|---|
Effects of a novel selective peroxisome proliferator-activated receptor-α modulator, pemafibrate, on hepatic and peripheral glucose uptake in patients with hypertriglyceridemia and insulin resistance.
Topics: Adult; Blood Glucose; Female; Glucose; Glucose Clamp Technique; Humans; Hypertriglyceridemia; Insulin Resistance; Liver; Liver Circulation; Male; Methylmethacrylates; Middle Aged; Povidone; PPAR alpha; Treatment Outcome | 2018 |
2 other study(ies) available for n-vinyl-2-pyrrolidinone and Insulin Resistance
Article | Year |
---|---|
Solubilization of luteolin in PVP40 solid dispersion improves inflammation-induced insulin resistance in mice.
Topics: Animals; Calorimetry, Differential Scanning; Inflammation; Insulin Resistance; Luteolin; Mice; Povidone; Solubility; Water | 2022 |
The effect of two different high-flux dialysis membranes on insulin resistance in non-diabetic end-stage renal disease patients.
Topics: Aged; Blood Glucose; Fasting; Female; Humans; Insulin; Insulin Resistance; Kidney Failure, Chronic; Male; Membranes, Artificial; Middle Aged; Nylons; Pharmaceutic Aids; Polymers; Povidone; Renal Dialysis; Sulfones | 2015 |